Company / Current Assets per Share
Esperion Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$2.23
FY2025
5-year range
$1.81 / $12.14
FY2021-FY2025
Trend
+23.2%
vs FY2024
Sector context
#173 of 210
Health Care
What the data says
Esperion Therapeutics, Inc.'s current assets per share of $2.23 is lower than 82% of companies in the Health Care sector (FY2025). Current Assets per Share returned to growth in FY2025 after 4 years of decline, reaching $2.23.
Based on SEC 10-K filings.
2.23 in FY2025 with a 5-year CAGR of -29.3%.
Improved from $1.95 to $2.23 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -15.7%
- 5-Year CAGR
- -29.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 210This company $2.23 Sector average $170.65
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 23.2% year-over-year.
- Ranks #173 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.23 | +23.2% |
| FY2024 | $1.81 | -7.4% |
| FY2023 | $1.95 | -47.5% |
| FY2022 | $3.71 | -69.4% |
| FY2021 | $12.14 | -3.5% |
| FY2020 | $12.58 | +59.4% |
| FY2019 | $7.89 | +48.0% |
| FY2018 | $5.33 | -37.4% |
| FY2017 | $8.52 | -10.1% |
| FY2016 | $9.47 | -2.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026